期刊文献+

天津地区汉族人群COMT基因多态性与脑梗死相关性研究 被引量:1

Association of COMT gene polymorphisms with cerebral infarction in Han people of Tianjin
下载PDF
导出
摘要 研究背景儿茶酚胺氧位甲基转移酶(COMT)是儿茶酚胺的主要代谢酶,催化儿茶酚胺第3位羟基甲基化,降解儿茶酚胺,同时亦是雌激素的主要代谢酶。COMT基因在rs4680位点存在鸟嘌呤腺嘌呤(G-A)点突变,使其编码的第108和(或)158位氨基酸由缬氨酸(Val)变为蛋氨酸(Met),导致儿茶酚胺氧位甲基转移酶活性降低。已知COMT基因多态性与精神疾病、酒精依赖、药物不良反应等有关,而与脑梗死之间的关系尚不明确,本研究旨在探讨COMT基因多态性与脑梗死之间的关系。方法通过聚合酶链反应限制性酶切片段长度多态性方法检测181例天津地区汉族脑梗死患者COMT Val及Met基因型,以及不同基因型脑梗死患者血糖、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇,以及载脂蛋白A和B水平。结果脑梗死组Val等位基因频率(78.45%)及Val/Val纯合子基因型(61.33%)均高于正常对照组(68.24%和45.95%),差异具有统计学意义(P<0.05);进一步分析显示男性Val等位基因频率(82.52%)与正常对照组(66.67%)之间差异亦存在统计学意义(P<0.01),而女性患者组间差异(69.83%对69.07%)无统计学意义(P>0.05)。脑梗死组Val/Val型与Val/Met+Met/Met型比较,血糖、血脂水平及高血压患病率差异无统计学意义(均P>0.05)。结论 COMT Val等位基因频率和Val/Val纯合子基因型是男性脑梗死患者的遗传学危险因素,COMT对脑梗死的影响与血糖、血脂及血压无明显相关性。 Background .Catechol- O- methyltransferase (COMT) has a key function in the degradation of catecholamines and inactivating estrogen. A common polymorphism in the COMT gene is guanine-adenine (G-A) point mutation on rs4680, which causes a valine (Val) substitution to methionine (Met) in 108 and (or) 158 amino acid by this gene and is responsible for lowered activity of the enzyme. The Val/Met polymorphism has been recognized to be associated with psychiatric disorders, alcohol dependence and drug side effects, but few study has been done to examine the relationship with cerebral infarction (CI). The objective of this study is to investigate the relationship between the polymorphisms of COMT gene and CI. Methods The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect COMT Va1158Met geuotype in 181 CI patients and 148 cases of controls. Meanwhile the serum levels of glucose, total cholesterol (TC), triglyccride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (ApoB) and ApoA in CI group were detected. Results The frequency of Val allele (78.45%) and Val/Val genotype (61.33%) in CI was significantly higher than that in the control group (68.24% and 45.95%, P 〈 0.05). Further analysis showed the frequency of Val allele in CI was significant higher in men (82.52% vs 66.67%, P 〈 0.01), butnot in women (69.83% vs 69.07%, P 〉 0.05) than that in the control group. The serum levels of glucose, TC, TG, LDL-C, HDL-C, ApoB, ApoA and the frequency of hypertension had no difference between Val/Val genotype and Val/Met + Met/Met genotypes (P 〉 0.05, for all). Conclusion The frequencies of Val allele and Val/Val genotype can be considered as genetic risk factors of male CI patients. The effect of COMT on CI is not related to blood pressure, serum lipid and glucose.
出处 《中国现代神经疾病杂志》 CAS 2013年第4期302-307,共6页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 天津市科技计划资助项目(项目编号:12ZCZDSY02900) 天津市卫生局科技攻关项目(项目编号:11KG117)~~
关键词 多态现象 遗传 儿茶酚O-甲基转移酶 脑梗死 天津 汉族 Polymorphism, genetic Catechol O-methyltransferase Brain infarction Tianjin Han nationality 1'
  • 相关文献

参考文献2

二级参考文献18

  • 1Kim SH, Choi JH, Park HS, et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy, 2005, 35:585-590.
  • 2Kim JH, Lee SY, Kim HB, et al. TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma. Clin Exp Allergy, 2008, 38:51-59.
  • 3Hirata T, Kakizuka A, Ushikubi F, et al. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest, 1994, 94:1662-1667.
  • 4Okuma M, Hirata T, Ushikubi F, et al. Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2. Pol J Pharmacol, 1996, 48:77-82.
  • 5Fuse I, Higuchi W, Aizawa Y. Arg60 Leu mutation in the first cytoplasmic loop of the platelet thromboxane A2 receptor is not essential for mediating inhibitory coupling between the receptor and adenylyl cyelase. Acta Haematol, 2000, 104(2/3):95-98.
  • 6Francois H, Athirakul K, Mao L, et aI. Role for thromboxane receptors in angiotensin- II -induced hypertension. Hypertension, 2004, 43:364-369.
  • 7Thomas DW, Mannon RB, Mannon PJ, et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Cliu Invest, 1998, 102:1994-2001.
  • 8Francois H, Makhanova N, Ruiz P, et al. A role for the throm- boxane receptor in L-NAME hypertension. Am J Physiol Renal Physiol, 2008, 295:F1096-1102.
  • 9Cambria-Kiely JA, Gandhi PJ. Aspirin resistance and genetic polymorphisms. J Thromb Thrombolysis, 2002, 14:51-58.
  • 10Fontana P, Gandrille S, Remones V, et al. Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers. Thromb Haemost, 2006, 96:356-360.

共引文献13

同被引文献23

  • 1Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y, Naghavi M, Vos T, Wang I-I, Lopez AD, Murray CJ. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet, 2013, 381: 1987-2015.
  • 2Ionita CC, Xavier AR, Kirmani JF, Dash S, Divani AA, Qureshi AI. What proportion of stroke is not explained by classic risk factors? Prey Cardiol, 2005, 8:41-46.
  • 3Hassan A, Markus HS. Genetics and isehaemic stroke. Brain, 2000, 123(Pt 9):1784-1812.
  • 4Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V, Assanelli D, Caimi L, Padovani A. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke, 2005, 36:533-539.
  • 5Warnhohz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Behm M, Meinertz T, Mtinzel T. Increased NADH-oxidase- mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin - angiotcnsin system. Circulation, 1999, 99:2027-2033.
  • 6Wei Z, Costa K, A1-Mehdi AB, Dodia C, Muzykantov V, Fisher AB. Simulated ischemia in flow to generation of reactive oxygen Res, 1999, 85:682-689.
  • 7Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V, Bobik A. Cytochrome b558- dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2002, 22:2037-2043.
  • 8Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation, 1998, 97:135-137.
  • 9Renner W, Schallmoser K, Gallippi P, Krauss C, Toplak H, Wascher TC, Pilger E. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease. Atherosclerosis, 2000, 152:175-179.
  • 10Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res, 2000, 86:391-395.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部